Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,697 | 165 | 87.8% |
| Education | $358.93 | 13 | 11.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.97 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $641.97 | 33 | $0 (2024) |
| Amgen Inc. | $623.81 | 46 | $0 (2024) |
| PFIZER INC. | $311.38 | 21 | $0 (2023) |
| TherapeuticsMD, Inc. | $215.23 | 11 | $0 (2022) |
| AbbVie Inc. | $213.61 | 15 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $180.94 | 11 | $0 (2020) |
| Aspira Women's Health Inc | $139.62 | 3 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $121.65 | 4 | $0 (2023) |
| HOLOGIC INC | $97.50 | 5 | $0 (2017) |
| Sumitomo Pharma America, Inc. | $84.53 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.49 | 12 | Amgen Inc. ($182.42) |
| 2023 | $571.11 | 21 | Astellas Pharma US Inc ($188.56) |
| 2022 | $393.20 | 17 | Astellas Pharma US Inc ($161.79) |
| 2021 | $47.98 | 3 | UROVANT SCIENCES INC ($18.52) |
| 2020 | $144.09 | 10 | Astellas Pharma US Inc ($46.37) |
| 2019 | $752.68 | 49 | TherapeuticsMD, Inc. ($156.66) |
| 2018 | $402.50 | 34 | Amgen Inc. ($145.30) |
| 2017 | $458.98 | 33 | Amgen Inc. ($120.22) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: HORMONE THERAPY | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Biological | ||||||
| 09/26/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.89 | General |
| 08/29/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: HORMONE THERAPY | ||||||
| 07/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Bone Health | ||||||
| 05/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Bone Health | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Biological | ||||||
| 04/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Bone Health | ||||||
| 02/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Biological | ||||||
| 02/16/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $137.81 | General |
| Category: Bone Health | ||||||
| 01/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Biological | ||||||
| 12/21/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $77.33 | General |
| 11/10/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: WOMENS HEALTH | ||||||
| 10/24/2023 | AbbVie Inc. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: WOMENS HEALTH | ||||||
| 10/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Biological | ||||||
| 09/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: Biological | ||||||
| 08/16/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Biological | ||||||
| 06/27/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Biological | ||||||
| 05/25/2023 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $51.01 | General |
| 05/25/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Urology | ||||||
| 04/13/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Bone Health | ||||||
| 03/29/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 887 | 6,603 | $353,419 | $160,646 |
| 2022 | 14 | 900 | 6,730 | $327,675 | $152,012 |
| 2021 | 12 | 807 | 6,287 | $283,472 | $129,504 |
| 2020 | 10 | 692 | 5,256 | $257,380 | $110,953 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 55 | 5,580 | $189,120 | $101,922 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 275 | $38,775 | $16,170 | 41.7% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 62 | 94 | $21,808 | $7,763 | 35.6% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 65 | 95 | $19,855 | $6,965 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 69 | $14,352 | $5,982 | 41.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 156 | 156 | $18,564 | $5,493 | 29.6% |
| 58340 | Insertion of tube and introduction of contrast for x-ray of uterus and fallopian tubes | Office | 2023 | 17 | 18 | $10,023 | $3,094 | 30.9% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2023 | 16 | 16 | $12,749 | $2,517 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 56 | $4,648 | $2,158 | 46.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 53 | 53 | $4,558 | $2,133 | 46.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 53 | 53 | $3,922 | $1,966 | 50.1% |
| 76831 | Ultrasound scan of uterus and uterine cavity | Office | 2023 | 15 | 16 | $3,449 | $1,357 | 39.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,180 | $1,277 | 30.5% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 12 | 12 | $3,096 | $932.76 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 54 | 90 | $4,320 | $914.17 | 21.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 52 | 5,700 | $182,400 | $96,554 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 226 | $31,866 | $13,920 | 43.7% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 72 | 100 | $23,200 | $7,492 | 32.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 73 | 105 | $21,945 | $7,411 | 33.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 113 | 113 | $9,718 | $4,628 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 51 | $10,608 | $4,370 | 41.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 113 | 113 | $8,362 | $4,295 | 51.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 110 | 110 | $13,076 | $3,840 | 29.4% |
| 58340 | Insertion of tube and introduction of contrast for x-ray of uterus and fallopian tubes | Office | 2022 | 16 | 16 | $6,896 | $2,936 | 42.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 45 | $3,735 | $1,736 | 46.5% |
About Dr. Ann Smith, MD
Dr. Ann Smith, MD is a Gynecology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184624231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Smith, MD has received a total of $3,073 in payments from pharmaceutical and medical device companies, with $302.49 received in 2024. These payments were reported across 179 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,697).
As a Medicare-enrolled provider, Smith has provided services to 3,286 Medicare beneficiaries, totaling 24,876 services with total Medicare billing of $553,114. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Toledo, OH
- Active Since 07/29/2005
- Last Updated 06/21/2011
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1184624231
Products in Payments
- EVENITY (Biological) $315.76
- Prolia (Biological) $285.70
- PREMARIN (Drug) $268.69
- INTRAROSA (Drug) $180.94
- Myrbetriq (Drug) $168.49
- OVA1 (Device) $156.00
- Orilissa (Drug) $135.06
- Veozah (Drug) $133.27
- BIJUVA (Drug) $122.27
- MYRBETRIQ (Drug) $92.78
- Novasure (Device) $89.51
- MYFEMBREE (Drug) $63.78
- GEMTESA (Drug) $53.65
- Lupron (Drug) $51.79
- XTANDI (Drug) $51.69
- Da Vinci Surgical System (Device) $51.58
- IMVEXXY (Drug) $49.25
- NEXTSTELLIS (Drug) $44.32
- Osphena (Drug) $44.25
- ANNOVERA (Drug) $43.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Toledo
Dr. Roshinder Padda
Gynecology — Payments: $3,477
David Tullis, Md, MD
Gynecology — Payments: $1,616
James Kiyak, M.d, M.D
Gynecology — Payments: $594.47
Megan Lutz, Md, MD
Gynecology — Payments: $569.11
Mrs. Snehalata Labhsetwar, M.d, M.D
Gynecology — Payments: $84.59